OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES
This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …
Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium
Primary vitreoretinal lymphoma (PVRL), also known as primary intraocular lymphoma, is a
rare malignancy typically classified as a diffuse large B‐cell lymphoma and most frequently …
rare malignancy typically classified as a diffuse large B‐cell lymphoma and most frequently …
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
AJ Souers, JD Leverson, ER Boghaert, SL Ackler… - Nature medicine, 2013 - nature.com
Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic
process. This family comprises proapoptotic and prosurvival proteins, and shifting the …
process. This family comprises proapoptotic and prosurvival proteins, and shifting the …
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide …
TM Green, KH Young, C Visco… - Journal of clinical …, 2012 - ascopubs.org
Purpose Approximately 5% of diffuse large B-cell lymphomas (DLBCLs) are double-hit
lymphomas (DHLs) with translocations of both MYC and BCL2. DHLs are characterized by …
lymphomas (DHLs) with translocations of both MYC and BCL2. DHLs are characterized by …
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Follicular lymphoma (FL) and the GCB subtype of diffuse large B-cell lymphoma (DLBCL)
derive from germinal center B cells. Targeted resequencing studies have revealed mutations …
derive from germinal center B cells. Targeted resequencing studies have revealed mutations …
Stromal gene signatures in large-B-cell lymphomas
G Lenz, G Wright, SS Dave, W **ao… - … England Journal of …, 2008 - Mass Medical Soc
Background The addition of rituximab to combination chemotherapy with
cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has …
cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has …
The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo
FA Karreth, M Reschke, A Ruocco, C Ng, B Chapuy… - Cell, 2015 - cell.com
Research over the past decade has suggested important roles for pseudogenes in
physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to …
physiology and disease. In vitro experiments demonstrated that pseudogenes contribute to …
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
Mutations disabling the TP53 tumour suppressor gene represent the most frequent events in
human cancer and typically occur through a two-hit mechanism involving a missense …
human cancer and typically occur through a two-hit mechanism involving a missense …
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
G Lenz, GW Wright, NCT Emre… - Proceedings of the …, 2008 - National Acad Sciences
Gene-expression profiling has been used to define 3 molecular subtypes of diffuse large B-
cell lymphoma (DLBCL), termed germinal center B-cell-like (GCB) DLBCL, activated B-cell …
cell lymphoma (DLBCL), termed germinal center B-cell-like (GCB) DLBCL, activated B-cell …
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
M Hummel, S Bentink, H Berger… - … England Journal of …, 2006 - Mass Medical Soc
Background The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma
is unclear. We used transcriptional and genomic profiling to define Burkitt's lymphoma more …
is unclear. We used transcriptional and genomic profiling to define Burkitt's lymphoma more …